A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
CLINUVEL PHARMACEUTICALS LTD reported its tenth consecutive annual profit with steady revenues of approximately AUD 94 million and increased cash reserves reaching AUD 252 million for FY2026. The company declared a stable dividend of AUD 0.05 per share, marking the ninth consecutive annual dividend. Despite a slight decline in revenues and profit c…